Get Anticoagulant and Antiplatelet Update from CME Webcast. We now have many new anticoagulant and antiplatelet drugs for physicians to choose from but more choices means that it can be harder to select the best drug for any given clinical situation. On this CME webcast, we are going to help you pick the best anticoagulant and the best antiplatelet for your patients. We’re pleased to welcome two anticoagulation experts from the Ohio State University. Tiffany Ortman is a clinical pharmacist who will be updating us about anticoagulants. And Danielle Blais is also a clinical pharmacist who will be updating us about antiplatelets.
What you’ll learn in this webcast
As a result of this educational activity, webcast participants will be able to: DETERMINE optimal oral anticoagulant based on patient-specific characteristics; RECOMMENDED monitoring for direct oral anticoagulants; DESCRIBE the role of aspirin and oral P2Y12 inhibitors for patients with stable ischemic heart disease or acute coronary syndromes with or without percutaneous coronary intervention; and EVALUATE the advantages and disadvantages of the different P2Y12 inhibitors.
You’ll also learn about the following:
- The spectrum of anticoagulants
- New anti-platelet drugs
- Direct oral anticoagulant costs and insurance coverage
- Home INR monitoring
You can find this and many other MedNet21 programs on the OSU – CCME website.
Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.